Related Concept Videos
Articles linked to this work by shared authors, journal, and citation graph.
The plasminogen activator inhibitor 1 4G/5G polymorphism is not associated with longevity: a study in octogenarians.
Journal of molecular medicine (Berlin, Germany)·2001
[An uncommon cause of severe soft tissue bleeding during phenprocoumon treatment].
Deutsche medizinische Wochenschrift (1946)·2001
Clinical differences between benign and malignant pheochromocytomas.
Endocrine journal·2001
Troglitazone and rosiglitazone inhibit the low density lipoprotein-induced vascular smooth muscle cell growth.
Experimental and clinical endocrinology & diabetes : official journal, German Society of Endocrinology [and] German Diabetes Association·2001
[Neuroendocrine tumors of the stomach (stomach carcinoid)].
Schweizerische Rundschau fur Medizin Praxis = Revue suisse de medecine Praxis·1994
[Time of drug intake in hypertension and angina pectoris. A controlled monitoring study].
Schweizerische Rundschau fur Medizin Praxis = Revue suisse de medecine Praxis·1994
[Mental suffering IN patients with parkinsonism].
Schweizerische Rundschau fur Medizin Praxis = Revue suisse de medecine Praxis·1994
[Liver transplantation 1994].
Schweizerische Rundschau fur Medizin Praxis = Revue suisse de medecine Praxis·1994
[Diagnosis and therapy of portosystemic encephalopathy].
Schweizerische Rundschau fur Medizin Praxis = Revue suisse de medecine Praxis·1994
[Ascites].
Schweizerische Rundschau fur Medizin Praxis = Revue suisse de medecine Praxis·1994
Occurrence of Infusion Associated Reactions and Antidrug Antibodies in Enzyme Replacement Therapy for Fabry Disease and the Effect of Preventive Measures.
Journal of inherited metabolic disease·2026
Amyloid-Related Imaging Abnormalities Summit Special Proceedings: Cardiovascular and Stroke Considerations for β-Amyloid Immunotherapy in Alzheimer Disease.
Journal of the American Heart Association·2026
Toward Personalized Theranostics: A Modular PET Platform for Antibody-Based Imaging and Therapy.
Advanced science (Weinheim, Baden-Wurttemberg, Germany)·2026
Targeted Degradation of KAT6A: Expanding the Therapeutic Frontier of Epigenetic Drug Discovery.
ACS medicinal chemistry letters·2026